Alternative cleavage and polyadenylation: Extent, regulation and function

Nature Reviews Genetics

Volumn 14, Issue 7, 2013, Pages 496-506

  Elkon, Ran ^a   Ugalde, Alejandro P ^a   Agami, Reuven ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN; LONG UNTRANSLATED RNA; MESSENGER RNA; POLYADENYLIC ACID; POLYNUCLEOTIDE ADENYLYLTRANSFERASE; SMALL NUCLEAR RIBONUCLEOPROTEIN; TRANS ACTING FACTOR; TRANSCRIPTION ELONGATION FACTOR; VASCULOTROPIN RECEPTOR 2;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DNA METHYLATION; EXPRESSED SEQUENCE TAG; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE MAPPING; HUMAN; IN VITRO SELECTION; NUCLEOSOME; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; POLYADENYLATION; POLYENDOCRINOPATHY; PRIORITY JOURNAL; PROTO ONCOGENE; REGULATORY MECHANISM; REVIEW; RNA BINDING; RNA CLEAVAGE; RNA SEQUENCE; RNA STABILITY; TRANSCRIPTION ELONGATION;

3' UNTRANSLATED REGIONS; ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CHROMATIN; CHROMOSOME MAPPING; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HUMANS; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLY A; POLYADENYLATION; PROTEIN ISOFORMS; RNA; RNA SPLICING;

EID: 84879408529     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg3482     Document Type: Review

References (89)

1. Edmonds, M. & Abrams, R. Polynucleotide biosynthesis: formation of a sequence of adenylate units from adenosine triphosphate by an enzyme from thymus nuclei. J. Biol. Chem. 235, 1142-1149 (1960).
2. Proudfoot, N. J. Ending the message: poly(A) signals then and now. Genes Dev. 25, 1770-1782 (2011).
3. Sachs, A. The role of poly(A) in the translation and stability of mRNA. Curr. Opin. Cell Biol. 2, 1092-1098 (1990). (Pubitemid 120039606)
4. Guhaniyogi, J. & Brewer, G. Regulation of mRNA stability in mammalian cells. Gene 265, 11-23 (2001). (Pubitemid 32209246)
5. D'Ambrogio, A., Nagaoka, K. & Richter, J. D. Translational control of cell growth and malignancy by the CPEBs. Nature Rev. Cancer 13, 283-290 (2013).
6. Martin, G., Gruber, A. R., Keller, W. & Zavolan, M. Genome-wide analysis of pre-mRNA 3′ end processing reveals a decisive role of human cleavage factor I in the regulation of 3′ UTR length. Cell Rep. 1, 753-763 (2012).
7. Fabian, M. R., Sonenberg, N. & Filipowicz, W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351-379 (2010).
8. Andreassi, C. & Riccio, A. To localize or not to localize: mRNA fate is in 3′UTR ends. Trends Cell Biol. 19, 465-474 (2009).
9. Gautheret, D., Poirot, O., Lopez, F., Audic, S. & Claverie, J. M. Alternate polyadenylation in human mRNAs: a large-scale analysis by EST clustering. Genome Res. 8, 524-530 (1998). (Pubitemid 28256800)
10. Beaudoing, E., Freier, S., Wyatt, J. R., Claverie, J. M. & Gautheret, D. Patterns of variant polyadenylation signal usage in human genes. Genome Res. 10, 1001-1010 (2000). (Pubitemid 30608635)
11. Tian, B., Hu, J., Zhang, H. & Lutz, C. S. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 33, 201-212 (2005). (Pubitemid 40276942)
12. Brown, K. M. & Gilmartin, G. M. A mechanism for the regulation of pre-mRNA 3′ processing by human cleavage factor Im. Mol. Cell 12, 1467-1476 (2003). (Pubitemid 38037015)
13. Sandberg, R., Neilson, J. R., Sarma, A., Sharp, P. A. & Burge, C. B. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320, 1643-1647 (2008). (Pubitemid 351931255)
14. Wang, E. T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470-476 (2008). (Pubitemid 352759009)
15. Pickrell, J. K. et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464, 768-772 (2010).
16. Sun, Y., Fu, Y., Li, Y. & Xu, A. Genome-wide alternative polyadenylation in animals: insights from high-throughput technologies. J. Mol. Cell. Biol. 4, 352-361 (2012).
17. Shi, Y. Alternative polyadenylation: new insights from global analyses. RNA 18, 2105-2117 (2012).
18. Hoque, M. et al. Analysis of alternative cleavage and polyadenylation by 3′ region extraction and deep sequencing. Nature Methods 10, 133-139 (2012).
19. Zhang, H., Lee, J. Y. & Tian, B. Biased alternative polyadenylation in human tissues. Genome Biol. 6, R100 (2005).
20. Ji, Z., Lee, J. Y., Pan, Z., Jiang, B. & Tian, B. Progressive lengthening of 3′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc. Natl Acad. Sci. USA 106, 7028-7033 (2009).
21. Hilgers, V. et al. Neural-specific elongation of 3′ UTRs during Drosophila development. Proc. Natl Acad. Sci. USA 108, 15864-15869 (2011).
22. Shepard, P. J. et al. Complex and dynamic landscape of RNA polyadenylation revealed by PAS-seq. RNA 17, 761-772 (2011).
23. Smibert, P. et al. Global patterns of tissue-specific alternative polyadenylation in Drosophila. Cell Rep. 1, 277-289 (2012).
24. Ulitsky, I. et al. Extensive alternative polyadenylation during zebrafish development. Genome Res. 22, 2054-2066 (2012).
25. Ji, Z. & Tian, B. Reprogramming of 3′ untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types. PLoS ONE 4, e8419 (2009).
26. Elkon, R. et al. E2F mediates enhanced alternative polyadenylation in proliferation. Genome Biol. 13, R59 (2012).
27. Timmusk, T. et al. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10, 475-489 (1993). (Pubitemid 23111738)
28. Lau, A. G. et al. Distinct 3′UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF). Proc. Natl Acad. Sci. USA 107, 15945-15950 (2010).
29. Flavell, S. W. et al. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 60, 1022-1038 (2008).
30. Takagaki, Y. & Manley, J. L. Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. Mol. Cell 2, 761-771 (1998). (Pubitemid 128378984)
31. Takagaki, Y., Seipelt, R. L., Peterson, M. L. & Manley, J. L. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 87, 941-952 (1996). (Pubitemid 26404292)
32. Yao, C. et al. Transcriptome-wide analyses of CstF64-RNA interactions in global regulation of mRNA alternative polyadenylation. Proc. Natl Acad. Sci. USA 109, 18773-18778 (2012).
33. Kubo, T., Wada, T., Yamaguchi, Y., Shimizu, A. & Handa, H. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3′-UTRs. Nucleic Acids Res. 34, 6264-6271 (2006). (Pubitemid 44942747)
34. Kim, S. et al. Evidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylation. Genes Cells 15, 1003-1013 (2010).
35. Venkataraman, K., Brown, K. M. & Gilmartin, G. M. Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition. Genes Dev. 19, 1315-1327 (2005). (Pubitemid 41003021)
36. Nunes, N. M., Li, W., Tian, B. & Furger, A. A functional human poly(A) site requires only a potent DSE and an A-rich upstream sequence. EMBO J. 29, 1523-1536 (2010).
37. Maniatis, T. & Reed, R. An extensive network of coupling among gene expression machines. Nature 416, 499-506 (2002). (Pubitemid 34288845)
38. Perales, R. & Bentley, D. "Cotranscriptionality": the transcription elongation complex as a nexus for nuclear transactions. Mol. Cell 36, 178-191 (2009).
39. Shi, Y. et al. Molecular architecture of the human pre-mRNA 3′ processing complex. Mol. Cell 33, 365-376 (2009).
40. Di Giammartino, D. C., Nishida, K. & Manley, J. L. Mechanisms and consequences of alternative polyadenylation. Mol. Cell 43, 853-866 (2011).
41. Nagaike, T. et al. Transcriptional activators enhance polyadenylation of mRNA precursors. Mol. Cell 41, 409-418 (2011).
42. Rozenblatt-Rosen, O. et al. The tumor suppressor CDC73 functionally associates with CPSF and CstF 3′ mRNA processing factors. Proc. Natl Acad. Sci. USA 106, 755-760 (2009).
43. Martincic, K., Alkan, S. A., Cheatle, A., Borghesi, L. & Milcarek, C. Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing. Nature Immunol. 10, 1102-1109 (2009).
44. Ji, Z. et al. Transcriptional activity regulates alternative cleavage and polyadenylation. Mol. Syst. Biol. 7, 534 (2011).
45. Pinto, P. A. et al. RNA polymerase II kinetics in polo polyadenylation signal selection. EMBO J. 30, 2431-2444 (2011).
46. de la Mata, M. et al. A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell 12, 525-532 (2003). (Pubitemid 37238937)
47. Spies, N., Nielsen, C. B., Padgett, R. A. & Burge, C. B. Biased chromatin signatures around polyadenylation sites and exons. Mol. Cell 36, 245-254 (2009).
48. Wood, A. J. et al. A screen for retrotransposed imprinted genes reveals an association between X chromosome homology and maternal germ-line methylation. PLoS Genet. 3, e20 (2007).
49. Cowley, M., Wood, A. J., Bohm, S., Schulz, R. & Oakey, R. J. Epigenetic control of alternative mRNA processing at the imprinted Herc3/Nap1l5 locus. Nucleic Acids Res. 40, 8917-8926 (2012).
50. Millevoi, S. et al. An interaction between U2AF 65 and CF I(m) links the splicing and 3′ end processing machineries. EMBO J. 25, 4854-4864 (2006). (Pubitemid 44607030)
51. Millevoi, S. & Vagner, S. Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation. Nucleic Acids Res. 38, 2757-2774 (2010).
52. Tian, B., Pan, Z. & Lee, J. Y. Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing. Genome Res. 17, 156-165 (2007). (Pubitemid 46220760)
53. Licatalosi, D. D. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464-469 (2008). (Pubitemid 352759008)
54. Kaida, D. et al. U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature 468, 664-668 (2010).
55. Berg, M. G. et al. U1 snRNP determines mRNA length and regulates isoform expression. Cell 150, 53-64 (2012).
56. Jenal, M. et al. The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 149, 538-553 (2012).
57. de Klerk, E. et al. Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation. Nucleic Acids Res. 40, 9089-9101 (2012).
58. Hilgers, V., Lemke, S. B. & Levine, M. ELAV mediates 3′ UTR extension in the Drosophila nervous system. Genes Dev. 26, 2259-2264 (2012).
59. Mansfield, K. D. & Keene, J. D. Neuron-specific ELAV/Hu proteins suppress HuR mRNA during neuronal differentiation by alternative polyadenylation. Nucleic Acids Res. 40, 2734-2746 (2012).
60. Zhu, H., Zhou, H. L., Hasman, R. A. & Lou, H. Hu proteins regulate polyadenylation by blocking sites containing U-rich sequences. J. Biol. Chem. 282, 2203-2210 (2007). (Pubitemid 47076748)
61. Castelo-Branco, P. et al. Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol. Cell. Biol. 24, 4174-4183 (2004). (Pubitemid 41070991)
62. Danckwardt, S. et al. Splicing factors stimulate polyadenylation via USEs at non-canonical 3′ end formation signals. EMBO J. 26, 2658-2669 (2007). (Pubitemid 46884270)
63. Bava, F. A. et al. CPEB1 coordinates alternative 3′-UTR formation with translational regulation. Nature 495, 121-125 (2013).
64. Danckwardt, S., Hentze, M. W. & Kulozik, A. E. 3′ end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J. 27, 482-498 (2008). (Pubitemid 351225676)
65. Park, J. Y. et al. Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory modules. PLoS ONE 6, e22391 (2011).
66. Mayr, C. & Bartel, D. P. Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138, 673-684 (2009).
67. Fu, Y. et al. Differential genome-wide profiling of tandem 3′ UTRs among human breast cancer and normal cells by high-throughput sequencing. Genome Res. 21, 741-747 (2011).
68. Lin, Y. et al. An in-depth map of polyadenylation sites in cancer. Nucleic Acids Res. 40, 8460-8471 (2012).
69. Morris, A. R. et al. Alternative cleavage and polyadenylation during colorectal cancer development. Clin. Cancer Res. 18, 5256-5266 (2012).
70. 6 metabolism in lung cancer. Cell Rep. 2, 257-269 (2012).
71. Akman, B. H., Can, T. & Erson-Bensan, A. E. Estrogen-induced upregulation and 3′-UTR shortening of CDC6. Nucleic Acids Res. 40, 10679-10688 (2012).
72. Vorlova, S. et al. Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation. Mol. Cell 43, 927-939 (2011).
73. Ingolia, N. T., Brar, G. A., Rouskin, S., McGeachy, A. M. & Weissman, J. S. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nature Protoc. 7, 1534-1550 (2012).
74. Kole, R., Krainer, A. R. & Altman, S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nature Rev. Drug Discov. 11, 125-140 (2012).
75. Yoon, O. K. & Brem, R. B. Noncanonical transcript forms in yeast and their regulation during environmental stress. RNA 16, 1256-1267 (2010).
76. Derti, A. et al. A quantitative atlas of polyadenylation in five mammals. Genome Res. 22, 1173-1183 (2012).
77. Beck, A. H. et al. 3′-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS ONE 5, e8768 (2010).
78. Jan, C. H., Friedman, R. C., Ruby, J. G. & Bartel, D. P. Formation, regulation and evolution of Caenorhabditis elegans 3′UTRs. Nature 469, 97-101 (2011).
79. Ozsolak, F. et al. Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell 143, 1018-1029 (2010).
80. Friedel, C. C., Dolken, L., Ruzsics, Z., Koszinowski, U. H. & Zimmer, R. Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res. 37, e115 (2009).
81. Colgan, D. F. & Manley, J. L. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 11, 2755-2766 (1997). (Pubitemid 27481677)
82. Mandel, C. R., Bai, Y. & Tong, L. Protein factors in pre-mRNA 3′-end processing. Cell. Mol. Life Sci. 65, 1099-1122 (2008).
83. Yang, Q., Coseno, M., Gilmartin, G. M. & Doublie, S. Crystal structure of a human cleavage factor CFI(m)25/CFI(m)68/RNA complex provides an insight into poly(A) site recognition and RNA looping. Structure 19, 368-377 (2011).
84. Higgs, D. R. et al. Alpha-thalassaemia caused by a polyadenylation signal mutation. Nature 306, 398-400 (1983). (Pubitemid 14242757)
85. Orkin, S. H., Cheng, T. C, Antonarakis, S. E. & Kazazian, H. H. Jr. Thalassemia due to a mutation in the cleavage-polyadenylation signal of the human ß-globin gene. EMBO J. 4, 453-456 (1985).
86. Gieselmann, V., Polten, A., Kreysing, J. & von Figura, K. Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. Proc. Natl Acad. Sci. USA 86, 9436-9440 (1989). (Pubitemid 20010441)
87. Barth, M. L, Fensom, A. & Harris, A. Prevalence of common mutations in the arylsulphatase A gene in metachromatic leukodystrophy patients diagnosed in Britain. Hum. Genet. 91, 73-77, 1993 (Pubitemid 23098533)
88. Bennett, C. L. et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome. Immunogenetics 53, 435-439 (2001). (Pubitemid 32906982)
89. Yasuda, M., Shabbeer, J., Osawa, M. & Desnick, R. J. Fabry disease: novel a-galactosidase A 3'-terminal mutations result in multiple transcripts due to aberrant 3'-end formation. Am. J. Hum. Genet. 73, 162-173 (2003). (Pubitemid 36793788)